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Edited by Jesus AvilaAbstract Recent reports have indicated that insect antimicrobial
peptides kill bacteria by inhibiting themolecular chaperoneDnaK.
It was proposed that the antimicrobial peptide, all-L-pyrrhocoricin
(L-PYR), binds to two sites on DnaK, the conventional substrate-
binding site and the multi-helical C-terminal lid, and that
inhibition of DnaK comes about from the lid mode of binding. In
this report, we show using two diﬀerent assays that L-PYRbinds to
and stimulates the ATPase activity of both wild-type and a lidless
variant of DnaK. Our study shows that L-PYR interacts with
DnaK much like the all-L NR (NRLLLTG) peptide, which is
known to bind in the conventional substrate-binding site of DnaK.
L-PYR antimicrobial activity is thus a consequence of the
competitive inhibition of bacterial DnaK.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Pyrrhocoricin1. Introduction
The E. coli 70-kDa molecular chaperone DnaK functions
co-translationally and post-translationally to promote protein
folding and to inhibit the formation of toxic protein aggregates
[1–3]. The DnaK reaction cycle is regulated by the two
co-chaperones, DnaJ and GrpE. Homologs of the DnaK/DnaJ/
GrpE chaperone machine are found in nearly all organisms,
which indicates the important role this chaperone machine
plays in maintaining proper protein cellular homoeostasis.
In an ATP-dependent reaction cycle, DnaK grabs a stretch
of exposed hydrophobic residues on partially denatured pro-
tein and, by an unknown mechanism, refolds the protein
molecule in concert with DnaK-mediated ATP hydrolysis.
Because the DnaK chaperone machine is absolutely essential
to repair partially denatured proteins that occur as a conse-
quence of stress, inhibiting DnaK would devastate a bacterial
cell. There have been intriguing reports of novel classes of* Corresponding author. Fax: +1-318-675-5180.
E-mail address: switt1@lsuhsc.edu (S.N. Witt).
Abbreviations: HEPES, N-(2-hydroxyethyl)piperazine-N 0-2-ethanesul-
fonic acid; p5, all-L synthetic peptide CLLLSAPRR; ap5, acrylodan-
labeledp5peptide; L-PYR,all-L aminoacidactive formofpyrrhocoricin;
D-PYR, all-D amino acid inactive pyrrhocoricin analog
0014-5793/$22.00  2004 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2004.03.075DnaK (Hsp70) [4] and DnaJ (Hsp40) [5] inhibitors. Such in-
hibitors, if they selectively bind to the prokaryotic but not to
the eukaryotic chaperone, could be an important new class of
antimicrobial agents. Having new antimicrobial agents is im-
portant given the frequency of multi-drug resistant bacterial
infections in hospital patients [6,7].
Multicellular organisms such as plants, animals and insects
synthesize protective peptides that kill bacteria. Antimicrobial
peptides are thought to kill by binding to the negatively
charged outer plasma membrane of bacteria, altering mem-
brane structure, and, in some cases, entering the cell to attack
cytosolic targets [8]. The class of antimicrobial peptides
secreted by insects, such as pyrrhocoricin, apidaecin, and
drosocin, are thought to kill bacteria by entering cells
and inhibiting the molecular chaperone DnaK [9]. Otvos
and colleagues proposed that L-pyrrhocoricin (L-PYR,
VDKGSYLPRPTPPRPIYNRN) binds predominately to a
‘non-conventional binding site’ on DnaK, that is, the aE and
aD helices of the multi-helical lid subdomain (Fig. 1), and that
L-PYR prevents DnaK’s lid from opening and closing [9]. Such
a novel mechanism is diﬀerent than L-PYR binding in the
conventional substrate-binding site of DnaK like a competitive
inhibitor.
In this report, the chemistry of L-PYR binding to DnaK was
studied using complementary pre-steady-state kinetic and
single turnover ATPase assays. The results indicate that
L-PYR binds to DnaK, even lidless DnaK, and stimulates the
ATPase activity of each DnaK species. On this basis, we thus
conclude that L-PYR binds primarily to the conventional
substrate-binding site of DnaK, much like other substrates,
and, by competing with natural substrates, L-PYR eﬀectively
decreases the cellular concentration of DnaK.2. Materials and methods
2.1. Protein and reagents
All reagents were of the highest purity and were purchased from
Sigma, unless stated otherwise. Wild-type and the lidless variant,
DnaK(2-517), were isolated and made free of bound nucleotide as
previously described [10,11] and were maintained in a HEPES buﬀer
(25 mM N-(2-hydroxyethyl)piperazine-N0-2-ethanesulfonic acid/50
mM KCl/5 mM MgCl2/5 mM 2-mercaptoethanol at pH 7.0). Protein
was stored in the HEPES sample buﬀer containing 10% glycerol at
)80 C prior to use. The p5, L-PYR, and D-PYR peptides were pur-
chased from Genemed Synthesis Incorporated (S. San Francisco, CA),
puriﬁed to >95% by high performance liquid chromatography, and
peptide masses were veriﬁed by electrospray mass spectroscopy.blished by Elsevier B.V. All rights reserved.
Fig. 1. Structure of the substrate-binding domain of DnaK (residues
394–607) [19]. The NR peptide (NRLLLTG), bound in the conven-
tional substrate-binding pocket, is depicted in black. The ﬁve a-helices
that comprise the lid are labeled A–E. The image was constructed from
PDB ﬁle 1DKX.
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A SX-18MV stopped-ﬂow ﬂuorescence spectrometer (Applied
Photophysics Ltd, Leatherhead, UK) was used to monitor two diﬀerent
reactions involving DnaK. ‘Reverse’ reactions, which involved mixing
ATP-bound DnaK with unlabeled peptide, were conducted with 295
nm excitation and a 320 nm long-pass ﬁlter [12]. Peptide dissociation
reactions, which involved mixing preformed ADPDnaK  ap5 com-
plexes with excess unlabeled peptide (100 lM), were conducted with
370 nm excitation and a 470 nm long-pass ﬁlter [13]. Preformed com-
plexes were prepared by incubating DnaK (2 lM) and ap5 (0.1 lM) in
1 mMADP for 30 min at room temperature. All stopped-ﬂow traces are
the average of 6–10 individual traces. Temperature control of both the
jacketed reactants and the jacketed mixing chamber was achieved with
a circulating external water bath (DT ¼ 0:2 C). Reagent concentra-
tions in the text refer to after mixing.
2.3. Single turnover ATPase assay
The single turnover ATPase assay was performed as described by
Karzai and McMacken [14]. Brieﬂy, the reaction mixture (30 ll) con-
tained 2.5 lMDnaK or DnaK(2-517), 51 nM ATP (0.05 lCi of [a-32P]-
ATP; 3000 Ci/mmol) in a HEPES buﬀer (25 mMHEPES/KOH, 10 mM
MgCl2, and 150mMKCl, pH7.6).Note thatK
þ is an essential co-factor
for Hsp70-mediated ATP hydrolysis [15,16]. To measure the peptide-
stimulated activity, peptide (p5, L-PYR, or D-PYR) concentration was
300lM.Sampleswere pre-incubated for 2min at 25 C.The reactionwas
initiated by the addition of ATP. Aliquots (3 ll) were removed period-
ically, quenched with 1 ll of 0.2 M HCl, and then 2 ll aliquots were
subjected to polyethyleneimine (PEI)–cellulose thin layer chromatog-
raphy using a 1M formic acid and 0.5M lithium chloride mobile phase.
Radio-labeled ATP and ADP were visualized and quantiﬁed using a
Phosphorimager (STORM 860). ADP formation traces followed single
exponential kinetics, where the ﬁrst-order rate constant is kcat (min1).
Non-enzymatic hydrolysis of ATP was determined for each experiment
and did not exceed 8 1.5% after 4 h incubation (n ¼ 17).
2.4. Curve ﬁtting
Stopped-ﬂow data were analyzed using a curve-ﬁtting program that
used a Marquardt algorithm based on the program Curﬁt given in [17].
Least squares ﬁtting of data and determinations of standard errors of
the ﬁtted parameters were conducted using the program KaleidaGraph
(Synergy Software, Reading, PA).3. Results
According to recent reports, L-PYR binds to wild-type
DnaK at two sites, the conventional substrate-binding site andthe aD and aE helices of the multi-helical lid [4,18]. In the ex-
periments described below the binding of L-PYR to the con-
ventional substrate-binding site of DnaK was characterized.
Short peptides that bind in the conventional substrate-
binding site of DnaK, such as NR (NRLLLTG) [19], p5
(CLLLSAPRR), and Cro (MQERITLKDYAM), rapidly bind
to ATP-bound DnaK (ATP DnaK*) and yield an increase in
the tryptophan ﬂuorescence of the protein [11,12] (Eq. (1)). We
recently discovered that L-PYR, when mixed with ATP 
DnaK*, also increases the tryptophan ﬂuorescence of DnaK.
Because of this ﬁnding, the reaction between ATP DnaK* and
L-PYR was investigated in detail. (The asterisk indicates that
ATP DnaK* is less ﬂuorescent than ATPDnaKP.)




ATP DnaK  P ðP ¼ peptideÞ ð1Þ
The kinetics of L-PYR binding to low-aﬃnity DnaK
(ATPDnaK)* were studied by stopped-ﬂow ﬂuorescence. The
experiments were carried out under pseudo-ﬁrst-order condi-
tions in which L-PYR concentration was varied at a ﬁxed con-
centration of ATP DnaK* (1 lM). Upon mixing L-PYR with
ATP DnaK* the intrinsic tryptophan ﬂuorescence of DnaK
rapidly increased, and the traces followed single exponential
kinetics over a range of L-PYR concentrations (Fig. 2A). Note
that control experiments demonstrated that no signal increase
occurred when ATP-bound DnaK was mixed with a negative
control peptide (polyglutamic acid or D-PYR). The plot of kobs
versus L-PYR concentration yielded kon and koff values of 2.3
(0.1) 105 M1 s1 and 6.7 (0.9) s1, respectively (Fig. 2B).
Interestingly, these constants are quite similar to the kinetic
constants for short synthetic peptides that bind to the conven-
tional substrate-binding site of DnaK (Table 1).
We were curious to see whether L-PYR binds to a lidless
variant of DnaK. To this end, rapid mixing experiments, like
those described above, were conducted using DnaK(2-517), a
variant that lacks 1/2 of the A helix, the aB–aE helices, and the
30 or so residues that constitute the ﬂexible C-terminal tail. In
general, peptides bind to DnaK(2-517) with about a 10-fold
lower aﬃnity than to the wild-type protein, and the lowered
aﬃnity is due almost entirely to a 10-fold increase in the rate of
peptide dissociation [11]. To achieve a reasonable ﬂuorescence
signal, a DnaK(2-517) concentration of 5 lM was used,
L-PYR concentration was varied from 100 to 400 lM, and
experiments were conducted at 5.6 C (to slow down peptide
dissociation). This experimental set up enabled us to estimate
kon and koff values for the reaction between L-PYR and ATP-
bound DnaK(2-517).
Fig. 3A shows representative formation traces obtained upon
mixing ATPDnaK(2-517)* with L-PYR. Signiﬁcantly, no sig-
nal change occurredwhen the inactive all-D isomer, D-PYR,was
used instead of the active all-L isomer. Each formation trace was
ﬁt to a single exponential function, yielding a value for kobs. The
plot of kobs versus L-PYR concentration yielded kon and koff
values of 7.6 (0.8) 104 M1 s1 and 11.6 (2.3) s1 (Kd ¼
koff=kon ¼ 153 lM), respectively (Fig. 3B). For comparison, the
p5 and theNRpeptide bind toATP-boundDnaK(2-517) at 5 C
with Kd equal to 73 lM (20:4 s1=2:8 105 M1 s) and 1455
lM (32 s1=2:2 104 M1 s) [11], respectively. The results
reveal that L-PYR speciﬁcally binds to lidless DnaK.
Most peptides that bind to DnaK stimulate DnaK-mediated
ATP hydrolysis. In contrast, it has been reported that
Fig. 2. L-PYR binding to ATP-bound DnaK monitored by tryptophan
ﬂuorescence. (A) ATPDnaKL-PYR complex formation followed
single exponential kinetics (solid line). Trace ‘‘C’’ was obtained by
mixing the negative control peptide, polyglutamic acid, with ATP-
bound DnaK. Conditions: concentrations after mixing, 1 lMDnaK, 1
mM ATP, and 10–100 lM L-PYR; temperature¼ 25 C. (B) Observed
rate constants plotted against L-PYR concentration. Data were ﬁt to
the equation kobs¼ kon [L-PYR] + koff (solid line, R ¼ 0:984), yielding
kon and koff values of 2.3 (0.1) 105 M1 s1 and 6.7 (0.9) s1,
respectively.
Fig. 3. L-PYR binding to ATP-bound DnaK(2-517) monitored by
tryptophan ﬂuorescence. (A) ATPDnaK(2-517)L-PYR complex for-
mation followed single exponential kinetics (solid line). For clarity,
traces are oﬀset from each other. Conditions: concentrations after
mixing, 5 lM DnaK(2-517), 1 mM ATP, 100–400 lM L-PYR or 300
lM D-PYR; temperature¼ 5.6 C. (B) Observed rate constants plotted
against L-PYR concentration. Data were ﬁt to the equation kobs¼ kon
[L-PYR] + koff (solid line, R ¼ 0:988), yielding kon and koff values of
7.6 (0.8) 104 M1 s1 and 11.6 (2.3) s1, respectively.
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binds to ATP-bound wild-type and lidless DnaK like other
short peptides, we tested whether L-PYR stimulates the
ATPase activity of both forms of DnaK using a single turnover
assay ([DnaK or DnaK(2-517)] [ATP]).
Fig. 4A shows representative single turnover ADP forma-
tion curves obtained from experiments using DnaK(2-517)
with or without L-PYR obtained at 25 C. In the absence of
peptide, DnaK(2-517) hydrolyzed ATP with a ﬁrst-order rate
constant, kcat, equal to 0.016 (0.001) min1, whereas in the
presence of 300 lM L-PYR kcat increased approximately 4-fold
to 0.061 (0.003) min1. Identical experiments were conducted
on wild-type DnaK. The combined results in Fig. 4B show that
on an average p5 produced a 6-fold stimulatory eﬀect onTable 1
Kinetic constants for the reverse reaction (1) at 25 C
Peptide (P) kon (M
1 s1) koff (s1)
NR 1.1 (0.1) 105 9.4 (1.0)
p5 9.4 (0.4) 105 7.0 (3.1)
Cro 2.4 (0.4) 104 2.9 (0.5)
L-PYR 2.3 (0.1) 105 6.7 (0.9)wild-type and lidless; whereas, on an average L-PYR produced
a 4-fold stimulatory eﬀect on wild-type and lidless.
It has been hypothesized that proline-rich antibacterial pep-
tides kill bacteria by preventing the frequent movements of the
multi-helical lid over the substrate-binding site [20]. We sought
to test this hypothesis using the following postulate as a basis for
the experimental design: If DnaK possesses two peptide binding
sites, then it is possible that DnaK forms a two-peptide complex
in which a short ﬂuorescently tagged peptide molecule, such as
aNR or ap5, is bound in the conventional substrate-binding site
and an L-PYR molecule is bound to the lid. If L-PYR inhibits
opening of the lid, then L-PYR should decrease the rate of ap5
dissociation from DnaK. This hypothesis was thus tested
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Fig. 4. Single turnover ATPase assay. (A) DnaK(2-517)-mediated ATP
hydrolysis with (dÞ and without (m) L-PYR. Data were ﬁt to the
equation ADP(t)¼ADPmax(1) exp[)kcat t]) (solid line), yielding
kcat()PYR) and kcat(+PYR) equal to 0.016 (0.001) and 0.061
(0.003) min1, respectively. Conditions: 2.5 lM DnaK(2-517), 300
lM PYR, and 51 nM ATP (0.05 lCi [a-32P] ATP/reaction); temper-
ature¼ 25 C. (B) ATPase activity (kcat) of wild-type and lidless DnaK.
Shown are results from the single turnover ATPase assay with no
peptide (NP), L-PYR, or D-PYR. Conditions: 300 lM p5, L-PYR or
D-PYR; temperature¼ 25 C. Each value is an average of at minimum
three experiments.
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L-PYR. As a baseline experiment, we found that upon mixing
preformed ADPDnaKap5 complexes with excess unlabeled p5
peptide (100 lM), the ap5 peptide dissociated with koff equal to
4.6 (0.1) 104 s1.When the same experimentwas conducted
with a large excess of unlabeled PYR (100 lM) instead of
unlabeled p5, the ap5 peptide dissociated with koff equal to 4.3
(0.1) 104 s1 (data not shown). That L-PYR did not
appreciably decrease the rate of ap5 dissociation indicates that
L-PYR does not inhibit opening of DnaK’s lid.4. Discussion
The results from this study show that L-PYR binds to DnaK
like a conventional substrate and that L-PYR does not inhibit
DnaK-mediated ATP hydrolysis. There were several factors
that lead us to hypothesize that L-PYR binds in the conven-









N) contains a classic DnaK-
binding site, i.e., a leucine residue ﬂanked by positively
charged residues. (A DnaK-binding motif contains a hydro-phobic core ﬂanked by positively charged residues [21]. Leu-
cine residues within the hydrophobic core are particularly
important, because the substrate-binding site of DnaK con-
tains a leucine-pocket [19].) (ii) DnaK has a propensity to bind
polycations like PYR. For example, protamine, which is a
polycationic peptide with antimicrobial activity, binds to DnaK
in a manner similar to short synthetic peptides [22]. (iii) The
inactivity of D-PYR to DnaK agrees with previous ﬁndings
that DnaK does not bind peptides composed of all-D amino
acids [5]. Overall, our results are consistent with L-PYR being
a pseudo-substrate of DnaK, i.e., a competitive inhibitor.
The main ﬁndings from previous studies [4,20] of PYR–
DnaK interactions are summarized as follows: (i) L-PYR in-
hibits the ATPase activity of DnaK; (ii) biotinylated-L-PYR
speciﬁcally binds to DnaK (590–615), which is a fragment
containing the aD–aE helices; (iii) biotinylated-L-PYR non-
speciﬁcally binds to both DnaK (397–439), which is a fragment
of the substrate-binding domain, and to DnaK (596–637),
which constitutes the aE helix and the 30-residue ﬂexible C-
terminus; and (iv) the N-terminal residues 1–9 of L-PYR
tightly bind to an ‘allosteric ATPase site’ on DnaK [20], which
explains the ability of L-PYR to inhibit DnaK-mediated ATP
hydrolysis. Aspects of these earlier ﬁndings and their relation
to our ﬁndings are discussed below.
It is important to deﬁne what is meant by the term ‘allo-
steric ATPase site’. Human and other eukaryotic Hsp70s
contain a highly conserved tetrapeptide (EEVD) carboxyl
terminus. (E. coli Hsp70 DnaK contains KDKK as the
carboxyl terminal residues.) Mutating EEVD to AAAA in
the human Hsp70 resulted in a 2-fold increase in the basal
ATPase activity, decreased tryptophan ﬂuorescence, and loss
of ATPase stimulation by the DnaJ-like co-chaperone HDJ-1
[23]. On this basis, Freeman et al. concluded that EEVD is a
regulatory motif that couples substrate recognition with
ATPase activity by binding to an allosteric site on the
ATPase domain. The question is whether DnaK contains
such an allosteric ATPase site. On the basis of dot blot
binding experiments and computer modeling, Kragol et al.
[20] concluded that PYR binds to the aD+ aE helices, and
because binding down regulated DnaK’s ATPase activity,
they hypothesized that the aD+ aE helices are the allosteric
ATPase site. Their hypothesis was reinforced by a recent
study showing that the ATPase activity of DnaK is allo-
sterically modulated by the C-terminal lid domain, particu-
larly by the aD+ aE helices [24]. However, in this study no
evidence was found that L-PYR inhibits DnaK-mediated
ATP hydrolysis. Presently, we cannot rule out that L-PYR
binds to the lid, although such an interaction is likely to be
quite weak.
The discrepancy between this study and earlier studies of
PYR–DnaK interactions is probably due to the diﬀerent buf-
fers and diﬀerent ATPase assays employed in the respective
studies. The single turnover assay used in this study was con-
ducted in a HEPES buﬀer with 150 mM potassium salt; [a-32P]
ATP was separated from [a-32P] ADP via PEI–cellulose thin
layer chromatography. This assay is widely used to measure
the rate of ATP hydrolysis by DnaK [14,25,26]. In contrast,
the spectrophotometric assay used in a previous study, which
detected the release of inorganic phosphate, was conducted in
a TRIS buﬀer without an essential potassium salt [20]. These
two assays probably give diﬀerent results because they utilized
diﬀerent buﬀers and measured diﬀerent phenomena.
L.S. Chesnokova et al. / FEBS Letters 565 (2004) 65–69 69In summary, on the basis of this study, we propose that the
primary binding site for L-PYR on DnaK is the conventional
substrate-binding pocket. By binding in the conventional
substrate-binding pocket of DnaK, L-PYR competitively in-
hibits DnaK, which thereby prevents natural substrates from
binding. Because of the high concentration of antimicrobial
peptides in the site of infection, organisms defend themselves
with high eﬃciency. Utilizing the knowledge that PYR binds
to the conventional substrate-binding site of DnaK might en-
able more eﬀective antimicrobial agents to be designed.
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